The University of Chicago Header Logo

Connection

James L. LaBelle to Antineoplastic Combined Chemotherapy Protocols

Back to Details
This is a "connection" page, showing publications James L. LaBelle has written about Antineoplastic Combined Chemotherapy Protocols.
James L. LaBelle
Connection Strength
0.129
Antineoplastic Combined Chemotherapy Protocols
  1. A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT. Blood Adv. 2023 02 14; 7(3):285-292.
    View in: PubMed
    Score: 0.104
  2. Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.